Skip to main content
. 2023 Oct 30;55:11626. doi: 10.2340/jrm.v55.11626

Fig. 3.

Fig. 3

(A) Total all-cause and (B) spasticity-related costs during the 12 months before and after onabotulinumtoxinA treatment, overall and by cost category. SD: standard deviation. Codes for other outpatient claims (outpatient claims and physical therapy claims) are described in Table SII.